GT Biopharma, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
GTBP on Nasdaq
Industry
Pharmaceutical Preparations
Location
8000 Marina Blvd, Suite 100, Brisbane, California

There are no Buy or Sell transactions made by insiders since 8/27/2023

GT Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Martin Breen Executive Chairman/Interim CEO, Director $246K Aug 11, 2023
Manu Ohri CFO & Secretary $100K Aug 11, 2023
Bruce Wendel Director Jan 27, 2023
Rajesh Shrotriya Director Jan 27, 2023
Gavin Choy Acting Chief Financial Officer Dec 31, 2021
Gregory Berk Pres. of R&D, CMO Jul 15, 2022
Charles J. Casamento Director Jun 16, 2023
Alan Urban Chief Financial Officer Jun 3, 2024

Recent Insider Transactions by Companies or Individuals for GT Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.